Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lung Neoplasms 1Hot Flashes 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Breast Neoplasms 1

Interventions

Gabapentin 3liposomal amphotericin B 2oxybutynin 1fezolinetant 1black cohosh root extract 1Venlafaxine Hydrochloride 1Vancomycin 1Testosterone 1Tazobactam 1Tamoxifen 1Tablets 1Sugars 1Soybean Proteins 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Levofloxacin 1Isoflavones 1Hypnosis 1Goserelin 1Folic Acid 1Filgrastim 1Estrogens, Conjugated (USP) 1Estradiol 1Cyproterone Acetate 1Citalopram 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hot Flashes × Folic Acid × Clear all
NCT06774885 2025-01-14

ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

Future University in Egypt

Phase 3 Not yet recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡